Oncology Learning Network CME

The Oncology Learning Network's CME podcast features expert discussion on clinical insights, the latest research updates, and changes in practice guidelines. With a broad range of content across all oncology specialties, medical professionals can stay informed about the topics that matter most to them. Earn CME at https://www.naccme.com/oln.

CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy

This episode outlines treatment barriers associated with the use of BTK inhibitors in CLL/SLL, including adverse events. Earn CME: https://www.naccme.com/oln

11-19
01:14:16

Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted Therapies

This episode address treatment barriers, adverse events, and healthcare disparities. Earn CME: https://www.naccme.com/oln

11-19
01:13:14

Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies

This episode discusses recently approved and emerging therapies in advanced HER2+ breast cancer. Earn CME: https://www.naccme.com/oln

11-19
01:14:06

Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen Therapy

This episode discusses the latest clinical trial data on current and emerging anti-androgen therapies in castration-resistant PC (CRPC) and hormone-sensitive PC (HSPC). Earn CME: https://www.naccme.com/oln

11-15
01:12:59

Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver Mutations

This episode identifies the strengths and limitations of molecular testing methodologies and genomic biomarkers for NSCLC identification, prognosis, and risk stratification. Earn CME: https://www.naccme.com/oln

11-10
01:11:58

Recommend Channels